Global 2016 Report: Stem Cell Research Products, Opportunities, Tools, & Technologies

Dublin, Feb. 08, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/5tdqlk/stem_cell) has announced the addition of the "Stem Cell Research Products - Opportunities, Tools, & Technologies" report to their offering.

This global strategic report will help you understand unique product opportunities by stem cell type, derive more revenue from products sold to stem cell scientists, and identify new product development opportunities before the competition. Use the Survey of Stem Cell Scientists to understand technical requirements, unmet needs, and purchasing preferences of stem cell researchers worldwide.

This report explores unique market opportunities by stem cell type, including mesenchymal stem cells, hematopoietic stem cells, induced pluripotent stem cells, embryonic stem cells, neural stem cells, and more.

The Market for Stem Cell Research Products

Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into any mature cell type. Several broad categories of stem cells exist, including:

- Embryonic stem cells, derived from blastocysts
- Perinatal stem cells, obtained during the period immediately before and after birth
- Adult stem cells, found in adult tissues
- Induced pluripotent stem cells, produced by genetically reprogramming adults cells
- Cancer stem cells, which give rise to clonal populations of cells that form tumors or disperse in the body

Stem cell research and experimentation have been in process for well over five decades, as stem cells have the unique ability to divide and replicate repeatedly. In addition, their unspecialized nature allows them to differentiate into a wide variety of specialized cell types.
In a developing embryo, stem cells can differentiate into all of the specialized embryonic tissues. In adult organisms, stem and progenitor cells act as a repair system for the body, replenishing specialized cells.

Traditionally, scientists have worked with both embryonic and adult stem cells as research tools. While the appeal of embryonic cells has been their ability to differentiate into any type of cell, there has been significant ethical, moral and spiritual controversy surrounding their use for research purposes. Although some adult stem cells do have differentiation capacity, it is often limited in nature, which results in fewer options for use.

Thus, when induced pluripotent stem cells (iPSCs) were produced from mouse cells in 2006 by Shinya Yamanaka of Kyoto University in Japan, they represented a promising combination of adult and embryonic stem cell characteristics. By 2007, a series of follow-up experiments were done at Kyoto University in which human adult cells were transformed into iPSC cells. Nearly simultaneously, a research group led by James Thomson at the University of Wisconsin-Madison accomplished the same feat of deriving iPSC lines from human somatic cells.

The possibilities arising from these characteristics have resulted in great commercial interest, with potential applications ranging from the use of stem cells in reversal and treatment of disease, to targeted cell therapy, tissue regeneration, pharmacological testing on cell-specific tissues, and more. Huntington's disease, Parkinson's disease, and spinal cord injuries are examples of conditions for which clinical applications involving stem cells could offer benefits in halting or even reversing adverse effects.

Also of interest to clinical researchers is the potential to use stem cells in regenerative medicine. Additionally, the ability to use stem cells to improve drug target validation and toxicology screening is of intense interest to the pharmaceutical industry.

At this time, the following account for the majority of stem cell research:

- Basic Research - Understanding stem cell mechanisms and behavior
- Regenerative Medicine - Reversal of injury or disease
- Drug Target Validation and Drug Delivery - Treatment of disease

Key report findings include:

- Market size determinations, with 5-year projections for the stem cell research products market (2016-2020)
- Year-over-year analysis of stem cell grant rates, patent rates, clinical trial rates, and scientific publication rates
- Stem cell funding sources, trends, and amounts (domestic and international)
- Stem cell research applications, including priorities by segment
- Relative demand for stem cell products, by stem cell type
- Breakdown of stem cell product categories
- Competitive analysis of leading stem cell research product companies
- Online trends for stem cells, including Google Trends and Google Adwords
- Social analytics for stem cells, including activity on Twitter, LinkedIn, Facebook, and more
- Communications strategies for accessing the marketplace
- End-user survey of stem cell scientists
- Toxicology Screening - Drug safety and efficacy assessment

Key Topics Covered:

I. Abstract

II. Purpose
A. Survey Recent Stem Cell Research Product Advancements
B. Provide a Snapshot of the Global Stem Cell Research Products Market
C. Assess Opportunities for Commercialization
D. Identify Major Market Players and Assess the Competitive Environment
E. Identify Existing and Emerging Trends
F. Identify Critical Opportunities and Threats within the Marketplace

III. Research Methodology
A. Input Sources
B. Research & Analysis Methodologies
C. Criteria for Identifying Market Leaders

IV. Key Events In The Development Of Stem Cell Research Products

V. Types Of Stem Cells
A. Human Embryonic Stem Cells (hESC)
B. Fetal Stem Cells (Pluripotent)
C. Umbilical Cord Stem Cells (Multipotent)
D. Adult Stem Cells (multipotent)
E. Cancer Stem Cells (Multipotent)
F. Induced Pluripotent Stem Cells (iPSCs)

VI. Stem Cell Research Applications
A. Basic Research
B. Regenerative Medicine (Cell-Based Therapies)
C. Drug Discovery & Development

VII. Key Competitors In The Stem Cell Research Products Marketplace
A. Thermo Fisher Scientific (Includes Life Technologies, Invitrogen, and Other Major Brands)
B. BD Biosciences (Division of Becton, Dickinson and Company)
C. Merck KGaA
D. Miltenyi Biotec
E. STEMCELL Technologies

VIII. Stem Cell Product Areas
A. Stem Cell Product Categories, by Type

IX. Emerging Areas Of Stem Cell Research
A. Induced Pluripotent Stem Cells (iPSCs)
B. Cord Blood Stem Cells
C. Dental Pulp Stem Cells
D. Adipose-Derived Stem Cell Storage

X. Market Size
A. Definitions
B. Methodology
C. Market Size Estimations
D. Five-Year Market Size Projections (2016-2020)

XI. Market Trend Analysis
A. Clinical Trial Analysis
B. Grant Analysis
C. Patent Analysis
D. Scientific Publication Rate Analysis
E. Funding of Stem Cell Initiatives

XII. Scientist Panel: Detailed End-User Survey
A. Survey Overview
B. Characterization of Market Survey Respondents
C. Survey Findings - General Scope
D. Survey Findings - Applied Stem Cell Research
E. Survey Findings - Comparison of Providers (Brand Preferences)
F. Survey Conclusions and Analysis

XIII. Strategies For Accessing The Marketplace
A. Top Research Institutions Performing Stem Cell Research
B. Top Countries for Stem Cell Research
C. Events of Interest

XIV. Social Analytics For Stem Cells
A. Marketing Cost Analysis for Stem Cells - Pay-Per-Click (PPC) Analysis
B. Stem Cell Articles Receiving Most Social Media Shares over Past 12 Months
C. Google Trend Data for Stem Cells
D. Twitter Hashtag Data
E. Top Five Stem Cell Influencers on Twitter

XV. Conclusions

Companies Mentioned

- BD Biosciences, a Division of Becton Dickinson
- Clontech (a Takara Bio Company)
- GE Healthcare Life Sciences.
- Lonza Group
- Merck KGaA
- Miltenyi Biotec
- STEMCELL Technologies
- Thermo Fisher Scientific

For more information visit http://www.researchandmarkets.com/research/5tdqlk/stem_cell